Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Macaluso

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Psychiatry|November 14, 2019
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E Thase, Sagar V Parikh, Anthony J Rothschild, et al.
Psychiatry Research|December 28, 2020
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depressionAnthony J Rothschild, Sagar V Parikh, Daniel Hain, et al.
Psychiatry Research|January 5, 2022
Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorderSagar V Parikh, Rebecca A Law, Daniel T Hain, et al.
Focus (American Psychiatric Publishing)|September 6, 2021
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With DepressionBrent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 10, 2020
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With DepressionBrent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
Journal of Psychiatric Research|January 25, 2019
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled studyJohn F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
Journal of Psychiatric Research|May 19, 2019
Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapiesJohn F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
Psychiatry Research|June 3, 2020
Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive DisorderRichard C Shelton, Sagar V Parikh, Rebecca A Law, et al.
The Journal of Clinical Psychiatry|July 17, 2025
Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial ReportScott T Aaronson, Charles R Conway, Charles Gordon, et al.
Schizophrenia Research|November 28, 2018
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA studyAlan Breier, Robert W Buchanan, Deepak D'Souza, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Psychiatry|November 14, 2019
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled TrialMichael E Thase, Sagar V Parikh, Anthony J Rothschild, et al.
Psychiatry Research|December 28, 2020
Clinical validation of combinatorial pharmacogenomic testing and single-gene guidelines in predicting psychotropic medication blood levels and clinical outcomes in patients with depressionAnthony J Rothschild, Sagar V Parikh, Daniel Hain, et al.
Psychiatry Research|January 5, 2022
Combinatorial pharmacogenomic algorithm is predictive of sertraline metabolism in patients with major depressive disorderSagar V Parikh, Rebecca A Law, Daniel T Hain, et al.
Focus (American Psychiatric Publishing)|September 6, 2021
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With DepressionBrent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 10, 2020
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With DepressionBrent P Forester, Sagar V Parikh, Sara Weisenbach, et al.
Journal of Psychiatric Research|January 25, 2019
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled studyJohn F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
Journal of Psychiatric Research|May 19, 2019
Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapiesJohn F Greden, Sagar V Parikh, Anthony J Rothschild, et al.
Psychiatry Research|June 3, 2020
Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive DisorderRichard C Shelton, Sagar V Parikh, Rebecca A Law, et al.
The Journal of Clinical Psychiatry|July 17, 2025
Prognostic and Prescriptive Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial ReportScott T Aaronson, Charles R Conway, Charles Gordon, et al.
Schizophrenia Research|November 28, 2018
Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA studyAlan Breier, Robert W Buchanan, Deepak D'Souza, et al.
Pageof 7